|
⚲
|
| Keyboard |
| Bybee Clinton
✚
|
|
|---|---|
| CIK # | 0001219043 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001219043] | |
| 4 | [0001219043] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Lyell Immunopharma Inc LYEL
Common Stock
|
2026-03-06 | Buy | 488,090 | $25.61 | 12,499,985 |
|
Neumora Therapeutics Inc NMRA
Common Stock
|
2025-10-27 | Buy | 1,915,700 | $2.61 | 4,999,977 |
|
Boundless Bio Inc BOLD
Series C Convertible Preferred Stock · derivative
|
2024-04-02 | Conversion | 164,835 | ||
|
Boundless Bio Inc BOLD
Series A Convertible Preferred Stock · derivative
|
2024-04-02 | Conversion | 424,908 | ||
|
Boundless Bio Inc BOLD
Common Stock
|
2024-04-02 | Conversion | 787,545 | ||
|
Boundless Bio Inc BOLD
Common Stock
|
2024-04-02 | Buy | 133,333 | $16.00 | 2,133,328 |
|
Boundless Bio Inc BOLD
Series C Convertible Preferred Stock · derivative
|
2024-04-02 | Conversion | 366,301 | ||
|
Boundless Bio Inc BOLD
Series C Convertible Preferred Stock · derivative
|
2024-04-02 | Conversion | 201,465 | ||
|
Boundless Bio Inc BOLD
Common Stock
|
2024-04-02 | Conversion | 589,743 | ||
|
Boundless Bio Inc BOLD
Common Stock
|
2024-04-02 | Conversion | 1,048,433 | ||
|
Boundless Bio Inc BOLD
Series B Convertible Preferred Stock · derivative
|
2024-04-02 | Conversion | 227,920 | ||
|
Boundless Bio Inc BOLD
Series A Convertible Preferred Stock · derivative
|
2024-04-02 | Conversion | 454,212 | ||
|
Boundless Bio Inc BOLD
Common Stock
|
2024-04-02 | Buy | 66,667 | $16.00 | 1,066,672 |
|
Boundless Bio Inc BOLD
Series A Convertible Preferred Stock · derivative
|
2024-04-02 | Conversion | 586,080 | ||
|
Sana Biotechnology Inc SANA
Common Stock
|
2024-02-08 | Buy | 727,272 | $5.50 | 3,999,996 |
|
Sana Biotechnology Inc SANA
Common Stock
|
2024-02-08 | Buy | 363,637 | $5.50 | 2,000,004 |
|
Sana Biotechnology Inc SANA
Common Stock
|
2024-02-08 | Buy | 727,272 | $5.50 | 3,999,996 |
|
Neumora Therapeutics Inc NMRA
Common Stock
|
2023-12-08 | Other | 703,061 | ||
|
Neumora Therapeutics Inc NMRA
Common Stock
|
2023-12-08 | Other | 1,176,593 | ||
|
Neumora Therapeutics Inc NMRA
Series A-1 Preferred Stock · derivative
|
2023-09-19 | Conversion | 1,144,973 | ||
| showing 20 of 200 most recent transactions | |||||